Media coverage about Integer (NYSE:ITGR) has trended somewhat positive on Thursday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Integer earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 45.2418210038824 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news headlines that may have effected Accern’s scoring:
- Integer Wins Long-Term Supply Agreement with Neuros Medical (finance.yahoo.com)
- Contrasting Medtronic (MDT) and Integer (ITGR) (americanbankingnews.com)
- Medtronic (MDT) versus Integer (ITGR) Critical Survey (americanbankingnews.com)
- Arch Therapeutics (ARTH) & Integer (ITGR) Head to Head Survey (americanbankingnews.com)
- Contrasting Integer (ITGR) & AxoGen (AXGN) (americanbankingnews.com)
A number of analysts have recently issued reports on ITGR shares. BidaskClub cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. Northcoast Research cut shares of Integer from a “buy” rating to a “neutral” rating in a research note on Monday, October 23rd. They noted that the move was a valuation call. Royal Bank Of Canada restated a “neutral” rating on shares of Integer in a research note on Friday, October 27th. Zacks Investment Research cut shares of Integer from a “hold” rating to a “sell” rating in a research note on Monday, August 28th. Finally, TheStreet cut shares of Integer from a “b-” rating to a “c+” rating in a research note on Thursday, November 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. Integer currently has a consensus rating of “Hold” and an average price target of $51.00.
Integer (NYSE:ITGR) opened at $44.45 on Thursday. Integer has a 1 year low of $28.70 and a 1 year high of $55.20. The company has a market cap of $1,467.90, a PE ratio of 17.04, a P/E/G ratio of 1.18 and a beta of 1.07. The company has a debt-to-equity ratio of 1.95, a quick ratio of 1.37 and a current ratio of 2.58.
Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The business had revenue of $363.31 million for the quarter, compared to analyst estimates of $354.83 million. During the same period last year, the firm earned $0.83 earnings per share. Integer’s revenue for the quarter was up 4.8% compared to the same quarter last year. analysts anticipate that Integer will post 2.62 EPS for the current year.
In related news, Director William B. Summers, Jr. sold 13,996 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $49.07, for a total transaction of $686,783.72. Following the transaction, the director now directly owns 46,179 shares of the company’s stock, valued at $2,266,003.53. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Timothy G. Mcevoy sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $49.35, for a total transaction of $172,725.00. Following the transaction, the vice president now directly owns 32,401 shares in the company, valued at $1,598,989.35. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,835 shares of company stock worth $2,557,378. 4.80% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This report was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.thelincolnianonline.com/2017/12/07/integer-itgr-receiving-somewhat-positive-news-coverage-report-finds.html.
Integer Company Profile
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Holdings Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer Holdings Co. and related companies with MarketBeat.com's FREE daily email newsletter.